Andrea Kuhnl, MD, King’s College Hospital, London, United Kingdom, discusses the impact of CAR T-cell therapy on the treatment of lymphoma patients in the UK as well as potential pitfalls associated with their use. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).